Norway· NO-ID_E2DC04B1-CF7A-4D58-9657-D85D35083C3C
Maxalt
A rizatriptan product containing rizatriptan benzoate, registered in Norway by N.V. Organon - Kloosterstraat. The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Rizatriptan is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CC04 (rizatriptan), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Rizatriptan · ATC N02CC04
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of rizatriptan costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $1.25 in France to $10.95 in Switzerland — a ×8.8 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rizatriptan · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$10.95
- ES Spain$5.01
- IT Italy$2.91
- FR France$1.25
The record
At a glance
FEST (Norway)- Active substance
- Rizatriptan Benzoate
- Manufacturer
- N.V. Organon - Kloosterstraat
- Country
- Norway (NO)
- ATC code
- N02CC04
- ATC class
- Rizatriptan
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_E2DC04B1-CF7A-4D58-9657-D85D35083C3C
- no_varenummer3947676NOK 209.6
- gtin840164511499
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
106 interactions on record for rizatriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rizatriptan · interactions on record
106 records
- 11 severe
- 6 moderate
- 88 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rizatriptan in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesrizatriptan benzoateGlenmark Pharmaceuticals Inc., USA
- SwedenMaxalt 5 mg TablettEbb Medical AB
- FinlandMaxaltN.V. Organon
- IrelandRizadia 5 mg TabletsOrganon Pharma (Ireland) Limited
- GermanyMaxaltOrganonhealthcare Gmbh
- BelgiumMaxalt 10 mgOrganon Belgium
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Maxalt, Maxalt Rapitab
- Belgium · Maxalt, Maxalt Lyo
- Germany · Maxalt, Maxalt Lingua
- Denmark · Maxalt Smelt, Rizatripan
- Spain · Maxalt, Maxalt Max
- Finland · Maxalt, Maxalt Rapitab
- France · Maxalt, Maxaltlyo
- United Kingdom (Northern Ireland) · Maxalt, Maxalt Melt
- Greece · Flixan, Maxalt
- Croatia · Maxalt Rpd
- Hungary · Calvinia
- Ireland · Rizadia
- Iceland · Maxalt Smelt, Rizatriptan Alvogen
- Italy · Emirizia, Maxalt
- Lithuania · Maxalt
- Luxembourg · Maxalt Lyo
- Latvia · Calvinia
- Malta · Rizatriptan Aurobindo Pharma (Malta)
- Netherlands · Maxalt, Maxalt Smelt
- Poland · Migrenofen
- Portugal · Maxalt, Rizatriptano Zim
- Romania · Maxalt
- Sweden · Maxalt, Maxalt Rapitab
- Slovakia · Maxalt Rpd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0df3335e-b01c-4243-b409-e244a73884e9 GET /v1/drugs/0df3335e-b01c-4243-b409-e244a73884e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Rizatriptan",
"merkevare_id": "ID_E2DC04B1-CF7A-4D58-9657-D85D35083C3C",
"name_form_strength": "Maxalt tab 5 mg",
"prescription_group": "C"
}See everything about rizatriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.